{
  "meta": {
    "title": "Appendegeal_Disorders_Part_1",
    "url": "https://brainandscalpel.vercel.app/appendegeal-disorders-part-1-aed4f940.html",
    "scrapedAt": "2025-11-30T11:11:52.832Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Infundibulum</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Bulge</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Hair bulb</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermal papillae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Stem cells of the hair follicle are present in?</span></p>",
      "unique_key": "DT1229328",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229328,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Stem cells of the hair follicle are present in <strong>Bulge.</strong></p>\n<p>The hair follicle is divided into two main regions:</p>\n<ul>\n<li><strong>Lower segment</strong> (bulb and suprabulbar region): from the base of the follicle to the insertion of the arrector pili muscle; this portion undergoes cyclical changes during the hair cycle.</li>\n<li><strong>Upper segment</strong>: from the insertion of the arrector pili muscle to the follicular orifice; this includes the <strong>infundibulum</strong> (from the skin surface to the opening of the sebaceous gland) and the <strong>isthmus</strong> (from the sebaceous gland to the arrector pili insertion).</li>\n</ul>\n<p><strong>Hair follicle stem cells</strong> are located in the <strong>bulge area</strong>, which is part of the <strong>lower isthmus</strong>, near the insertion of the arrector pili muscle. These <strong>multipotent stem cells</strong> serve as a reservoir for follicular regeneration.</p>\n<ul>\n<li>They migrate <strong>downward</strong> into the hair bulb during anagen to regenerate the lower follicle.</li>\n<li>They also migrate <strong>upward</strong> to contribute to sebaceous gland formation and to aid in <strong>wound healing</strong> by proliferating in response to skin injury.</li>\n</ul>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062741709c7e-7bab-4c65-864e-e7e7852adfb0.png\">",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">1 only</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">All of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Lanugo hair occurs in:<br />1. Fetus<br />2. Premature baby<br />3. Very low birth weight baby<br />4. Newborn</span></p>",
      "unique_key": "DT1229329",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229329,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li ><span >Lanugo is the </span><strong>first type of hair to develop in humans</strong><span >, appearing around the </span><strong>third month of fetal development</strong><span >.&nbsp;</span></li>\n<li ><span >It begins on the scalp (eyebrow, nose, and forehead area) and spreads </span><strong>cephalocaudally</strong><span >, covering most of the body </span><strong>except the palms and soles</strong><span >.&nbsp;</span></li>\n<li ><span >Lanugo is typically </span><strong>shed between 33&ndash;36 weeks of gestation</strong><span >, becoming part of </span><strong>amniotic fluid and meconium</strong><span >.&nbsp;</span></li>\n<li ><span >It is eventually replaced by </span><strong>vellus or terminal hair</strong><span >, but may persist in </span><strong>30% of newborns</strong><span >, especially in </span><strong>premature or very low birth weight infants</strong><span >.&nbsp;</span></li>\n<li><span >Rarely, lanugo in older individuals may indicate underlying pathology such as </span><strong>anorexia nervosa</strong><span >.</span></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626ba51be98-b6fd-4d22-b9a7-a73dd92d8a5d.png\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626a0c67d51-4d79-481e-966e-1b2e2c1dc3e4.png\">",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Anagen is the period of active growth</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">80% of hair is in anagen at one point of time</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Catagen involves cessation of melanin synthesis</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Telogen is the phase of involution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is incorrect about hair cycle?</span></p>",
      "unique_key": "DT1229500",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229500,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Telogen</strong><span > is a </span><strong>resting</strong><span > phase. </span><strong>Involution</strong><span > refers to the </span><strong>catagen phase</strong><span >, where regression and apoptosis occur.</span></p>\n<p><strong>Hair Cycle Phases </strong></p>\n<p><span >The growth of the hair follicle is cyclical. Stages of rapid growth and elongation of the hair shaft alternate with periods of quiescence and regression.</span></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626e49bf224-ee53-4c67-80b1-9aab138aab28.png\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506263ee50507-7a24-4f87-a09c-a10754d72c5b.png\">\n<p><strong>Clinical Relevance:</strong></p>\n<ul>\n<li><strong>Telogen effluvium</strong><span >: &uarr; Telogen % (&gt;20%) &rarr; diffuse hair shedding</span></li>\n<li><strong>Androgenetic alopecia</strong><span >: &darr; Anagen % and &uarr; Kenogen phase</span></li>\n<li><span ><strong>Alopecia areata</strong><span >: Sudden shift to catagen/telogen; exclamation-mark hairs</span><span ><br /></span></span></li>\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Bulge</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Infundibulum</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Hair bulb</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermal papilla</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old man presents with gradual thinning of hair over the temples and vertex. His father experienced similar hair loss in early adulthood. Examination reveals miniaturized hair follicles in the affected regions. Routine laboratory parameters are normal. Which of the following structures in the hair follicle is the primary target of androgen action in this condition?</span></p>",
      "unique_key": "DT1229503",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229503,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><span >The clinical picture is consistent with </span><strong>androgenetic alopecia (AGA)</strong><span >&mdash;a common, genetically influenced form of patterned hair loss seen in both men and women. It typically presents with </span><strong>gradual hair thinning over the vertex and frontotemporal regions</strong><span >, and shows a strong </span><strong>familial tendency</strong><span >.</span></p>\n<ul>\n<li ><span >The </span><strong>primary target of androgen action </strong><span >in AGA is the</span><strong> dermal papilla</strong><span >, a specialized mesenchymal structure at the base of the hair follicle. It contains </span><strong>androgen receptors</strong><span > and expresses the </span><strong>Type 2 isoform of 5&alpha;-reductase</strong><span >, which converts testosterone into </span><strong>dihydrotestosterone (DHT)</strong><span >&mdash;a more potent androgen with a higher affinity for the receptor.</span></li>\n<li ><span >In AGA, DHT binds with high affinity to androgen receptors in the dermal papilla, initiating signaling cascades that </span><strong>shorten the anagen (growth) phase</strong><span >. This results in </span><strong>miniaturization of hair follicles</strong><span >, where thick, pigmented </span><strong>terminal hairs</strong><span > are converted into </span><strong>short, fine, non-pigmented vellus hairs</strong><span >, ultimately leading to progressive hair loss.</span></li>\n<li ><span >The </span><strong>Type 2 5&alpha;-reductase isoform</strong><span > is found in the </span><strong>dermal papilla</strong><span >, </span><strong>sebaceous ducts</strong><span >, </span><strong>proximal inner root sheath</strong><span >, and </span><strong>inner layer of the outer root sheath</strong><span >, and plays a dominant role in AGA.</span></li>\n<li ><strong>Type 1 5&alpha;-reductase</strong><span >, by contrast, is located primarily in </span><strong>sebaceous glands</strong><span >, </span><strong>epidermis</strong><span >, </span><strong>eccrine and apocrine sweat glands</strong><span >, and </span><strong>liver</strong><span >, and has a lesser role in AGA pathogenesis.</span></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506263302ddce-0ff2-4381-b5d7-491660a912f7.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p><span >Patients with AGA often show:</span></p>\n<ul>\n<li ><span >&uarr; DHT levels</span></li>\n<li ><span >&uarr; 5&alpha;-reductase activity</span></li>\n<li ><span >&uarr; Androgen receptor density in the balding scalp</span><span ><br /></span></li>\n</ul>\n<p><span >These changes in the </span><strong>dermal papilla</strong><span > lead to:</span></p>\n<ul>\n<li ><span >Follicular miniaturization (Terminal &rarr; Vellus)</span></li>\n<li ><span >Shortened hair cycle</span></li>\n<li><span >Permanent hair loss in a patterned distribution</span><strong><br /></strong></li>\n</ul>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Isotretinoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman presents with a complaint of sudden, marked hair loss that began two weeks ago. On examination, there is diffuse hair thinning with broken hairs of varying lengths, but the scalp appears normal. She recently started a new medication as part of treatment for a systemic illness. Which of the following drugs is most likely responsible for this presentation?</span></p>",
      "unique_key": "DT1229508",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229508,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><span >The rapid onset of diffuse hair loss within 1&ndash;3 weeks, especially with broken hairs, is classic for </span><strong>Anagen Effluvium</strong><span >, a form of non-scarring alopecia, most often triggered by cytotoxic agents such as </span><strong>doxorubicin</strong><span >. These drugs damage rapidly proliferating hair matrix cells, leading to fragile, dystrophic anagen hairs.</span></p>\n<p><span >In contrast, </span><strong>heparin</strong><span >, </span><strong>propranolol</strong><span >, and </span><strong>isotretinoin</strong><span > are known to cause </span><strong>Telogen Effluvium</strong><span >, which has a delayed onset (~3 months after exposure) due to premature shift of follicles from anagen to telogen phase.</span></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062623787ff3-422c-4be8-b9c1-739fcd54c105.png\">",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Telogen effluvium</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgenetic alopecia</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Telogen effluvium</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Anagen effluvium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old woman presents with complaints of increased hair shedding for the past 3 months. She reports a history of typhoid fever 4 months ago. On examination, there is diffuse thinning of hair across the scalp with no signs of inflammation or scarring. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1229524",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229524,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Acute Telogen Effluvium (TE)</strong><span > is a form of </span><strong>acute-onset non-scarring scalp hair loss</strong><span > that typically begins </span><strong>around 3 months</strong><span > after a </span><strong>triggering event</strong><span >, such as a </span><strong>febrile illness</strong><span > (e.g., typhoid, COVID-19), major surgery, trauma, or sudden malnutrition. In this case, the temporal link between </span><strong>typhoid fever 4 months ago</strong><span > and the onset of </span><strong>hair shedding 3 months ago</strong><span > is classic.</span></p>\n<p><span >The mechanism is </span><strong>immediate anagen release</strong><span >, where a significant number of anagen (growing phase) hairs prematurely enter the telogen (resting phase), followed by shedding. Patients typically notice </span><strong>diffuse thinning</strong><span > rather than bald patches, and may report increased hair loss during combing or showering.</span></p>\n<ul>\n<li ><span >Hair loss is often </span><strong>not complete</strong><span >, but can be distressing due to visible thinning.</span></li>\n<li ><span >Shedding ranges from &lt;100 to &gt;1000 hairs daily.</span></li>\n<li ><span >Hair pull test may be strongly positive.</span></li>\n<li ><span >Spontaneous regrowth occurs in </span><strong>3&ndash;6 months</strong><span > unless the stressor persists.</span></li>\n<li ><span >Trichoscopy may reveal </span><strong>uniform shaft diameters</strong><span > and </span><strong>short regrowing hairs</strong><span >.</span></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Chronic Telogen Effluvium (Option A):</strong></p>\n<ul>\n<li ><span >Defined as telogen effluvium lasting </span><strong>&gt;6 months</strong></li>\n<li ><span >Often idiopathic or due to chronic illness or nutritional deficiencies.</span><span ><br /></span></li>\n</ul>\n<p><strong>Androgenetic Alopecia (Option C):</strong></p>\n<ul>\n<li ><span >Gradual onset, </span><strong>patterned hair loss</strong><span > (fronto-temporal recession and vertex thinning in women)</span></li>\n<li ><span >No abrupt shedding</span></li>\n<li ><span >Often </span><strong>familial</strong><span >, and not linked to recent illness</span><span ><br /></span></li>\n</ul>\n<p><strong>Anagen Effluvium (Option D):</strong></p>\n<ul>\n<li ><span >Occurs </span><strong>within 1&ndash;3 weeks of insult</strong><span >, typically </span><strong>chemotherapy, radiation</strong><span >, or </span><strong>toxic agents</strong></li>\n<li ><span >Characterized by </span><strong>broken, dystrophic hairs</strong></li>\n<li ><span >Sudden, extensive loss (up to 90% hairs)</span></li>\n</ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgenetic Alopecia</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Alopecia Areata</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Telogen Effluvium</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichotillomania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which disease is characterised by the findings shown below?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025100989692c48-7790-4757-995f-94a4284f4dcf.png\"></span></p>",
      "unique_key": "DT1229534",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229534,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The trichoscopy image from the alopecia areata, an autoimmune disease, shows the presence of hair with a broad distal tip and narrow/tapered proximal part. These are called exclamation mark hairs and are pathognomonic of alopecia areata.</p>\n<p><strong>Pathophysiology of Alopecia Areata:</strong></p>\n<p>In alopecia areata, a CD8+ T-cell&ndash;mediated attack targets anagen III&ndash;IV follicles, causing premature transition to telogen.</p>\n<p>Follicles re-enter anagen but are repeatedly arrested at stage III&ndash;IV, leading to ineffective growth and recurrent hair loss.</p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626d98901d2-cb88-472b-9c59-2a33d184de3f.png\" alt=\"\" />\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626aae9e200-27c4-4e62-a118-79fb28a55c9b.png\" alt=\"\" />",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Tzanck smear</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Gram stain</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Slit skin smear</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">KOH mount</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old patient presents with hair loss and scalp itching. Which of the following is most useful for diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626ee05d0a4-d870-4624-b119-104651912a03.png\"></span></p>",
      "unique_key": "DT1229543",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229543,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical presentation suggests <strong>Tinea capitis</strong>, most likely the <strong>black dot</strong> variant.</p>\n<p><strong>KOH mount</strong> helps detect <strong>dermatophytic hyphae</strong> in hair shafts or scales, making it the key diagnostic test.</p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506265cda1849-c6d2-46cd-9903-0e7fb11cf598.png\" alt=\"\" />\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626e9ee1a48-ebd1-4aeb-b058-2400cdb46a40.png\" alt=\"\" />\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Tzanck smear (Option A): </strong>Used to detect multinucleated giant cells in herpetic infections, not fungal scalp infections.</p>\n<p><strong>Gram stain (Option B): </strong>Useful for identifying bacteria, especially in bacterial skin infections&mdash;not dermatophytes.</p>\n<p><strong>Slit skin smear (Option C): </strong>Diagnostic for leprosy (Mycobacterium leprae), not appropriate for tinea capitis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626aafb125b-b253-4a07-9738-a48cfcb2cc05.png\" alt=\"\" />",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Pili annulati</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Pili torti</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichothiodystrophy</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Monilethrix</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-month-old male infant is brought to the pediatric clinic for evaluation of poor weight gain and developmental delay. The parents report frequent episodes of seizures and a recent unexplained fracture of the humerus. On examination, the child appears irritable and hypotonic, with sparse, brittle, and lightly pigmented hair that is twisted and feels coarse to touch. There is no family history of similar illness. Which of the following hair shaft abnormalities is most characteristic of this condition?</span></p>",
      "unique_key": "DT1229548",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li ><span >The clinical scenario describes </span><strong>Menkes disease</strong><span >, a genetic disorder of copper metabolism caused by ATP7A mutation.</span></li>\n<li ><span >The most characteristic hair shaft abnormality seen in this condition is </span><strong>pili torti</strong><span >, where hairs are flattened and twisted 180&deg; at irregular intervals along the shaft.</span></li>\n<li ><span >This twist makes the hair fragile and brittle, often resulting in breakage. Pili torti may also present with a spangled appearance in reflected light and is best confirmed on light microscopy.</span></li>\n<li ><span >Other characteristic features of Menkes disease include seizures, developmental delay, hypotonia, failure to thrive, frequent fractures, and low serum copper and ceruloplasmin levels. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626a656886b-d803-4c1d-b83a-3cb69e1f7d0e.png\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506262b967050-2ed5-45db-a05c-e05c08ce2607.png\"></span></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Pili annulati (Option A):</strong></p>\n<ul>\n<li ><span >Characterized by </span><strong>alternating light and dark bands</strong><span > due to </span><strong>air-filled cavities</strong><span > in the hair cortex.</span></li>\n<li ><span >The hair appears spangled in reflected light but is otherwise </span><strong>not fragile.</strong></li>\n<li ><span >Typically an incidental finding, not associated with systemic features. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626f1f09521-7f32-455e-9ea7-9b631c769890.png\"></span></li>\n<li><strong>Trichothiodystrophy (TTD) (Option C):</strong></li>\n<li ><span >A </span><strong>sulfur-deficiency hair disorder</strong><span >. Hair is </span><strong>brittle, short</strong><span >, and may show </span><strong>trichoschisis.</strong></li>\n<li ><span >On polarized light microscopy, it shows the characteristic </span><strong>\"tiger tail\" pattern</strong><span > due to alternating bright and dark bands.</span></li>\n<li ><span >Often associated with </span><strong>neuroectodermal syndromes.</strong><span ><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626fa73622f-9109-4d83-aa6a-be2a1848d766.png\"></span></li>\n<li><strong>Monilethrix (Option D):</strong></li>\n<li ><span >Features a </span><strong>beaded hair appearance</strong><span > with </span><strong>regular elliptical nodes and constricted internodes</strong><span >, giving a </span><strong>necklace-like look.</strong></li>\n<li ><span >Fragility and breakage occur at </span><strong>internodes.</strong></li>\n<li><span ><span >Often associated with </span><strong>follicular keratosis</strong><span >, especially on the </span><strong>nape and occiput</strong><span >, but </span><strong>not with systemic symptoms</strong><span > like seizures or fractures. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506263ce06fb5-5e58-4ac8-9a60-4acd10a6053d.png\"></span></span></li>\n</ul>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\"><p>Ludwig</p></span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\"><p>Sinclair</p></span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\"><p>Hamilton and Norwood</p></span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\"><p>SALT</p></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"><p>Which of the following can be used to grade this condition?<br>Â </p><figure class=\"image\"><img src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626d8e24b19-edd0-435e-a82c-24a775ebf548.png\"></figure></span></p>",
      "unique_key": "DT1279796",
      "question_audio": null,
      "question_video": null,
      "map_id": 1279796,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The image shows <strong>frontotemporal recession</strong> along with <strong>vertex thinning</strong>, which are classical signs of <strong>androgenetic alopecia (male pattern baldness)</strong>.</p><ul><li><strong>Androgenetic alopecia</strong> is a genetically predisposed condition characterized by <strong>progressive miniaturization of hair follicles</strong> in a patterned distribution.</li><li>It results from increased sensitivity to androgens in susceptible individuals.</li><li>The <strong>Norwood-Hamilton scale </strong>is commonly used to classify male-pattern baldness</li></ul><figure class=\"image\"><img src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626896e2dca-6aec-4154-871e-aee41da949cf.png\"></figure><figure class=\"image\"><img src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626f8fa7de9-39f2-48e9-9f30-ee87dc1b08e5.png\"></figure><figure class=\"image\"><img src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626312527ec-e91c-4b33-a7ce-f86a16d36789.png\"></figure><p><strong>Key Takeaway:</strong></p><ul><li><strong>Patterned Alopecia</strong>:<ul><li>Male: Hamilton-Norwood</li><li>Female: Ludwig, Sinclair, FPHL-SI</li></ul></li><li><strong>Alopecia Areata</strong>: SALT is the gold standard</li></ul>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Ophilasis means loss of hair along the hairline margin </span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Alopecia totalis means loss of all scalp hair </span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Alopecia universalis means loss of all body hair </span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Ophiasis has better prognosis than patchy alopecia areata</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is incorrect regarding alopecia areata?</span></p>",
      "unique_key": "DT1279800",
      "question_audio": null,
      "question_video": null,
      "map_id": 1279800,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Ophiasis is a <strong>poor prognostic marker.</strong></p>\n<p>Alopecia areata is a non-scarring, autoimmune-mediated hair loss disorder that commonly presents as well-demarcated patches of hair loss. Several clinical patterns exist:</p>\n<ul>\n<li><strong>Ophiasis</strong> refers to band-like hair loss along the temporal and occipital margins of the scalp <strong>(Option A ruled out)</strong>. It is considered a <strong>poor prognostic marker</strong> due to its chronic and treatment-resistant nature.</li>\n<li><strong>Alopecia totalis</strong> is defined as complete loss of <strong>scalp hair</strong>. <strong>(Option B ruled out)</strong></li>\n<li><strong>Alopecia universalis</strong> involves complete loss of <strong>all body hair</strong>, including scalp, eyebrows, and eyelashes. <strong>(Option C ruled out)</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250708e82aa663-d902-4570-931b-d61ce3725369.png\">\n<p><strong>Poor prognostic factors</strong> in alopecia areata include:</p>\n<ul>\n<li>Childhood onset</li>\n<li><strong><strong>Ophiasis pattern</strong></strong></li>\n<li>Extensive involvement <strong>(totalis/universalis)</strong></li>\n<li>Long duration of disease</li>\n<li>Association with atopy, autoimmune disorders, or Down syndrome</li>\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Fine regular nail pitting</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Coarse irregular nail pitting</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Longitudinal ridging of the nail</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Thinning of the nail</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy presents with patchy hair loss as shown below. Which of the following findings is most likely on nail examination?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626731f5b07-3e6c-4a49-adcd-00ffc7b48f2f.png\"></span></p>",
      "unique_key": "DT1279802",
      "question_audio": null,
      "question_video": null,
      "map_id": 1279802,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><span >The given clinical presentation is consistent with</span><strong> alopecia areata.</strong></p>\n<p><span >Alopecia areata is a non-scarring autoimmune alopecia. Nail involvement is seen in </span><strong>10&ndash;15%</strong><span > of patients, more commonly in those with </span><strong>extensive or severe disease</strong><span >.</span></p>\n<ul>\n<li><span >The </span><strong>most characteristic nail finding</strong><span > is </span><strong>fine, regular, geometric pitting</strong><span > (also called \"stippling\") of the nail plate.</span></li>\n<li><span >Other possible nail changes include:</span>\n<ul>\n<li><strong>Trachyonychia</strong><span > (rough, sandpaper-like nail plate surface)</span></li>\n<li><strong>Longitudinal ridging or splitting</strong></li>\n<li><strong>Red spotting of the lunula</strong></li>\n<li><strong>Nail thinning and dystrophy</strong><span > (less common)</span></li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626790c34ae-489b-4b33-adf4-93d37f07bbaf.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Coarse irregular Nail Pitting</strong> <strong>(Option B):</strong></p>\n<ul>\n<li><span >Seen in </span><strong>psoriasis</strong><span >, not alopecia areata.</span></li>\n<li><span >Psoriatic pitting is </span><strong>deeper, broader</strong><span >, and </span><strong>randomly distributed</strong><span >, often with </span><strong>oil-drop discoloration</strong><span > and </span><strong>onycholysis</strong><span >.</span></li>\n</ul>\n<p><strong>Longitudinal ridging of the nail (Option C):</strong></p>\n<ul>\n<li><span >Common in </span><strong>lichen planus</strong><span > and </span><strong>trachyonychia</strong><span >, but can also occur in aging.</span></li>\n<li><span >While </span><strong>trachyonychia</strong><span > (rough nails) can be associated with alopecia areata, </span><strong>longitudinal ridging</strong><span > is not the most characteristic finding.</span></li>\n</ul>\n<p><strong>Thinning of nail (Option D):&nbsp;</strong></p>\n<ul>\n<li><span >Can occur in </span><strong>atrophic nail dystrophy</strong><span > or </span><strong>systemic diseases</strong><span >, sometimes seen in advanced alopecia areata but </span><strong>not a hallmark feature</strong><span >.</span></li>\n<li><span >Thinning is </span><strong>non-specific</strong><span > and </span><strong>not diagnostic</strong><span > for alopecia areata.</span></li>\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Intralesional triamcinolone injection </span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Contact immunotherapy </span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral steroids </span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclosporine </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the treatment of choice for patients with patchy alopecia areata?</span></p>",
      "unique_key": "DT1279804",
      "question_audio": null,
      "question_video": null,
      "map_id": 1279804,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Patchy alopecia areata</strong><span > is the most common and localized form of alopecia areata. While several treatment options exist for alopecia areata, management depends on the extent and severity of involvement.</span></p>\n<p><span >In cases of </span><strong>limited patchy hair loss of short duration</strong><span >, </span><strong>spontaneous remission occurs in up to 80%</strong><span > of patients. However, when treatment is desired, </span><strong>intralesional corticosteroids</strong><span > are considered the </span><strong>treatment of choice</strong><span >.</span></p>\n<ul>\n<li ><strong>Triamcinolone acetonide</strong><span > (5&ndash;10 mg/mL) is most commonly used. It is administered via </span><strong>fine-needle intradermal injection</strong><span > into the </span><strong>upper subcutis</strong><span >.</span></li>\n<li ><span >Multiple sessions are usually required, with </span><strong>total doses not typically exceeding 20 mg</strong><span > per session.</span></li>\n<li ><span >The mechanism involves local immunosuppression that helps suppress T-cell-mediated attack on hair follicles.</span></li>\n<li ><span >Local </span><strong>skin atrophy</strong><span > is the most common side effect but usually resolves within a few months.</span></li>\n</ul>\n<p><strong>Treatment Approach Based on Extent:</strong></p>\n<ul>\n<li ><strong>Localized Patchy AA: </strong><span >Intralesional steroids (e.g., triamcinolone acetonide)</span></li>\n<li ><strong>Extensive AA (Alopecia Totalis / Universalis): </strong><span >Systemic steroids, cyclosporine, azathioprine, or JAK inhibitors (e.g., tofacitinib)</span></li>\n<li ><strong>Refractory Cases: </strong><span >Contact immunotherapy (e.g., DPCP) may be used, especially in diffuse or relapsing disease.</span></li>\n</ul>\n<p><strong>Explanation of Other options:</strong></p>\n<p><strong>Contact immunotherapy (Option B)</strong><span > is more suited for extensive or refractory AA (alopecia totalis/universalis), not initial patchy cases.</span></p>\n<p><strong>Oral steroids (Option C)</strong><span > may be used for rapidly progressive or extensive disease but are not preferred in limited patchy cases due to systemic side effects.</span></p>\n<p><strong>Cyclosporine (Option D)</strong><span > is generally reserved for resistant, extensive cases and is often combined with systemic steroids for better efficacy.</span><span ><br /></span></p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Premature canites </span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Alopecia areata </span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Anagen effluvium </span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Albinism </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Canities subita is a characteristic feature of:</span></p>",
      "unique_key": "DT1279806",
      "question_audio": null,
      "question_video": null,
      "map_id": 1279806,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Canities subita</strong><span > (&ldquo;sudden whitening of hair&rdquo;) refers to the rare phenomenon of hair appearing to turn white overnight. This is </span><strong>not due to rapid depigmentation</strong><span >, but rather due to </span><strong>preferential shedding of pigmented hairs</strong><span > in individuals with mixed pigmented and non-pigmented hair (e.g. greying adults).</span></p>\n<ul>\n<li ><span >In </span><strong>alopecia areata</strong><span >, the autoimmune attack selectively targets </span><strong>pigmented anagen hair follicles</strong><span >, sparing white (non-pigmented) hairs.</span></li>\n<li ><span >As a result, patients may experience sudden loss of only dark hairs, leaving white hairs behind and giving the illusion of \"sudden whitening\" of the scalp &mdash; </span><strong>canities subita</strong><span >.</span></li>\n<li ><span >This phenomenon is a </span><strong>classic but rare feature</strong><span > of alopecia areata.</span><span ><br /></span></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Premature canities (Option A): </strong><span >Refers to early onset of greying (before age 20 in Caucasians, 25 in Asians), due to melanocyte depletion&mdash;not associated with sudden onset or selective hair loss.</span><span ><br /></span></p>\n<p><strong>Anagen effluvium (Option C): </strong><span >Caused by toxic injury to rapidly dividing hair matrix cells (e.g., chemotherapy). Leads to sudden </span><strong>diffuse hair loss</strong><span >, but without selective targeting of pigmented hair, and </span><strong>does not cause canities subita</strong><span >.</span><span ><br /></span></p>\n<p><strong>Albinism (Option D):</strong><span > A genetic condition marked by </span><strong>complete or partial absence of melanin</strong><span > in hair, skin, and eyes from birth. The hair is already non-pigmented; hence </span><strong>not a sudden phenomenon</strong><span > and </span><strong>canities subita is not seen</strong><span >.</span></p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudopelade of Brocq</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Discoid lupus erythematosus </span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Moth-eaten alopecia</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">En coup de sabre </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a cicatricial alopecia?</span></p>",
      "unique_key": "DT1279808",
      "question_audio": null,
      "question_video": null,
      "map_id": 1279808,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Moth-eaten alopecia</strong><span style=\"font-weight: 400;\"> is a </span><strong>non-cicatricial (non-scarring)</strong><span style=\"font-weight: 400;\"> alopecia seen in </span><strong>secondary syphilis</strong><span style=\"font-weight: 400;\">, whereas Pseudopelade of Brocq, Discoid lupus erythematosus, and En coup de sabre are all cicatricial (scarring) alopecias.</span></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626fb885af0-3bfc-487d-9612-9d6633609829.png\">",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichorrhexis nodosa</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Netherton syndrome </span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Kinky hair syndrome </span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Uncombable hair syndrome </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">\"Bamboo hair,\" as shown in the image below, is characteristic of which of the following conditions?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506265218b803-558a-46f6-b62c-e6600cd9957d.png\"></span></p>",
      "unique_key": "DT1279810",
      "question_audio": null,
      "question_video": null,
      "map_id": 1279810,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><span >Bamboo hair (Trichorrhexis invaginata) is pathonomonic for</span><strong> Netherton syndrome.</strong></p>\n<ul>\n<li><span >Comel&ndash;Netherton syndrome (CNS) is a rare autosomal recessive disorder caused by mutations in the </span><strong>SPINK5 gene</strong><span >, characterized by a triad:</span>\n<ul>\n<li><strong>Congenital ichthyosis </strong><span >(Ichthyosis linearis circumflexa)</span></li>\n<li><strong>Atopic diathesis </strong><span >(e.g. eczema, elevated IgE)</span></li>\n<li><strong>Trichorrhexis invaginata (Bamboo hair)</strong><span > &ndash; pathognomonic</span></li>\n</ul>\n</li>\n<li><strong>Trichorrhexis invaginata</strong><span > occurs when the distal hair shaft telescopes into the proximal part, producing a </span><strong>\"ball-in-cup\"</strong><span > appearance. Multiple such invaginations give a </span><strong>\"bamboo-like\"</strong><span > appearance on microscopy or trichoscopy.</span></li>\n<li><span >Hairs are dry, brittle, and sparse &mdash; especially on the </span><strong>scalp, eyebrows, and eyelashes</strong><span >. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506268a7dd61c-81a4-4fd9-8764-73d9cc86e73d.png\"></span></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Trichorrhexis nodosa (Option A):</strong></p>\n<ul>\n<li><span >Represents </span><strong>mechanical or chemical damage</strong><span > to the hair shaft.</span></li>\n<li><span >Appears as </span><strong>white-grey nodes</strong><span > on the shaft due to splaying of cortical fibers.</span></li>\n<li><span >Classic </span><strong>\"paint brush\"</strong><span > or </span><strong>\"broomstick\"</strong><span > ends seen on light microscopy.</span></li>\n<li><span >Associated with trauma, zinc/biotin/iron deficiency, and metabolic conditions like </span><strong>argininosuccinic aciduria</strong><span >. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250626f0ebe85d-1c36-4ed1-bb20-a07f2d9e50f1.png\"></span></li>\n</ul>\n<p><strong>Pili torti (Kinky hair syndrome) (Option C):</strong></p>\n<ul>\n<li><span >Hair shafts are </span><strong>flattened and twisted 180&deg;</strong><span > at irregular intervals.</span></li>\n<li><span >Gives a </span><strong>spangled or iridescent appearance</strong><span > under light.</span></li>\n<li><span >Seen in various congenital disorders (e.g. </span><strong>Menkes disease</strong><span >) and acquired scarring alopecias.</span></li>\n<li><span >No bamboo appearance; rather a </span><strong>twisted shaft</strong><span > with fragility. <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506262b967050-2ed5-45db-a05c-e05c08ce2607.png\"></span></li>\n</ul>\n<p><strong>Uncombable hair syndrome (Option D):</strong></p>\n<ul>\n<li><span >Hairs are </span><strong>silvery-blond</strong><span >, dry, and </span><strong>stand out in all directions</strong><span >.</span></li>\n<li><span >Resists combing due to </span><strong>triangular or kidney-shaped cross-sections</strong><span > with </span><strong>longitudinal grooving</strong><span >.</span></li>\n<li><span >Diagnosed using </span><strong>polarized light or scanning electron microscopy</strong><span >, not associated with fragility like trichorrhexis nodosa or bamboo hair.</span></li>\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete frontal hairline recession with vertex baldness</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Christmas tree-like central thinning with preserved frontal hairline</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Diffuse unpatterned loss involving the occipital scalp</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Patchy hair loss with broken hairs and inflammation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old woman presents with complaints of gradual thinning of hair over the scalp for the past 2 years. She reports loss of hair volume and increased hair shedding, especially from the crown region. On examination, the central parting appears widened, and there is diffuse thinning over the mid-frontal scalp, with relative preservation of the frontal hairline.<br>Which of the following patterns of hair loss is most characteristic of this condition?</span></p>",
      "unique_key": "DT1324063",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324063,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span >The patient described has </span><strong>female pattern hair loss (FPHL), </strong><span >a form of </span><strong>androgenetic alopecia (AGA)</strong><span > in women, which presents with </span><strong>diffuse thinning over the mid-frontal scalp</strong><span > and </span><strong>widening of the central parting</strong><span >, often forming a \"Christmas tree\" appearance.</span></p>\r\n<p><strong>Androgenetic Alopecia: Male vs Female</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062740e987fe-d419-45a4-b7ec-bc965029df0a.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Diffuse unpatterned loss involving the occipital scalp (Option C): </strong><span >represents </span><strong>diffuse unpatterned alopecia</strong><span >, which is rare and more common in men&mdash;not typical FPHL.</span></p>\r\n<p><strong>Patchy hair loss with broken hairs and inflammation (Otion D):</strong><span > suggests </span><strong>inflammatory/scarring alopecia</strong><span > (e.g., tinea capitis, lichen Planopilaris), not AGA.</span><span ><br /></span></p>\r\n<ul>\r\n<li><strong>Key Takeaway:</strong></li>\r\n<li><span >FPHL = diffuse thinning + central part widening + preserved frontal hairline</span></li>\r\n<li><span >MPHL = frontotemporal + vertex loss + occipital sparing</span></li>\r\n<li><span >Hair diameter diversity is an early clue in women with AGA.</span></li>\r\n</ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Finasteride </span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyproterone acetate</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral corticosteroids</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Flutamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old man presents with progressive thinning of hair over the temples and vertex for the past 2 years. His father had a similar pattern of hair loss starting in his 30s. On examination, there is frontotemporal recession and decreased hair density over the crown. Trichoscopy shows increased hair diameter variability and miniaturized hair follicles. He is concerned about further hair loss and asks about treatment options. Which of the following is the most appropriate first-line pharmacological therapy for his condition?</span></p>",
      "unique_key": "DT1324066",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324066,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><span >The clinical picture is consistent with </span><strong>androgenetic alopecia (AGA)</strong><span >, also known as male pattern hair loss. This is a </span><strong>genetically predisposed</strong><span >, androgen-dependent condition characterized by </span><strong>progressive miniaturization of hair follicles</strong><span >, typically affecting the </span><strong>frontotemporal and vertex scalp</strong><span > regions in men.</span></p>\r\n<p><span >The first-line pharmacological therapy for AGA in men is </span><strong>Finasteride,</strong><span > at a </span><strong>dose of 1 mg/day</strong><span >.</span></p>\r\n<p><strong>Management of Androgenetic Alopecia (AGA)</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062747014249-0e55-4d9e-a889-a476d41b1177.png\">\r\n<p><span >Follicular Unit Extraction (FUE); Follicular Unit Transplant (FUT)&nbsp;</span></p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Cyproterone acetate (Option B):</strong></p>\r\n<ul>\r\n<li><span >Anti-androgen used primarily in </span><strong>women with androgen excess</strong><span > (e.g., PCOS-related FPHL).</span></li>\r\n<li><strong>Not approved or effective</strong><span > in male AGA due to risk of feminization and hepatotoxicity.</span><span ><br /></span></li>\r\n</ul>\r\n<p><strong>Oral corticosteroids (Option C):</strong></p>\r\n<ul>\r\n<li><span >Used in </span><strong>autoimmune hair loss</strong><span > (e.g., alopecia areata).</span></li>\r\n<li><span >No role in AGA, which is a </span><strong>hormone-driven</strong><span >, non-inflammatory condition.</span><span ><br /></span></li>\r\n</ul>\r\n<p><strong>Flutamide (Option D):</strong></p>\r\n<ul>\r\n<li><span >Potent androgen receptor blocker, occasionally used in </span><strong>women with hyperandrogenism</strong><span >.</span></li>\r\n<li><strong>Severe hepatotoxicity risk</strong><span >; </span><strong>not used in men</strong><span > due to feminizing side effects.</span></li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li><strong>Minoxidil</strong><span >: Safe for both sexes. Requires long-term use; initial shedding may occur.</span></li>\r\n<li><strong>Finasteride</strong><span >:</span>\r\n<ul>\r\n<li><span >FDA-approved for </span><strong>AGA</strong><span > (1 mg) and </span><strong>BPH</strong><span > (5 mg)</span></li>\r\n<li><strong>Not approved in women</strong><span > (contraindicated in pregnancy&mdash;teratogenic)</span></li>\r\n<li><span >May cause reversible sexual side effects (&darr; libido, erectile dysfunction)</span></li>\r\n</ul>\r\n</li>\r\n<li><strong>Dutasteride</strong><span >: Not FDA-approved for AGA; more potent than finasteride; long half-life</span></li>\r\n<li><strong>Hair transplant: </strong><span >Permanent restoration; result visible in 6&ndash;12 months</span></li>\r\n</ul>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}